Abstract:Vascular endothelial cells produce various biologically active factors regulating blood pressure, coagulation, and possibly cell growth of the vascular wall. Of the factors, nitric oxide (NO) has been the object of attention because of its quite simple molecular structure and variety of biological functions. In the present review, we focused on the physiologic and pathologic aspects of NO in hypertension. In experimental animals, both acute and chronic inhibition of NO synthase (NOS) with arginine derivatives produce a significant rise in blood pressure, indicating that tonic production of NO regulates basal vascular tonus. The chronic hypertension caused by NOS inhibitor is associated with cardiac hypertrophy and renal insufficiency. Sodium retention, though transient, and the plasma and tissue renin/angiotensin system in addition to the reduced production of NO have been implicated in the development of hypertension. Hypertension and the associated target organ failure can be reversed by co-administration of L-arginine or blockades of the renin/angiotensin system. Studies in which L-arginine as the substrate of NO or NOS inhibitor was administered demonstrated an important role of NO in the regulation of tonic vascular tonus also in normal subjects. In hypertensive subjects, however, endothelium-dependent vasorelaxation and production of NO are impaired, possibly due to a deficiency of L-arginine and/or a disorder of its utilization. Recent advances in the methods of detecting NO enabled us to demonstrate its diminished production from endothelial cells of hypertensive rats in vitro, although no definite biochemical evidence has been obtained in hypertensive subjects. The endothelial dysfunction, however, is not a primary cause of hypertension but a secondary result since it is commonly observed in various types of hypertension and can be reversed by correcting the blood pressure. Other common diseases including atherosclerosis and diabetes mellitus are also associated with similar abnormalities of the endothelium. NO has anti-atherogenic actions: inhibition of platelet functions and proliferation of vascular smooth muscle cells. Therefore, potentiation of endogenous NO and/or supplement of exogenous NO donors could be novel therapeutic approaches for the treatment of hypertension and atherosclerosis, while potential adverse effects of NO including cytotoxicity, immunosuppressibility, and hypotensive shock should be taken into account.

Progress in inhibitors of nitric oxide synthase

Specificity of Inducible Nitric-Oxide Synthase Inhibitors: Prospects for Their Clinical Therapy.

[Progress in the Studies on Neuronal Nitric Oxide Synthase Inhibitors].

Research Progress of Inducible Nitric Oxide Synthase Inhibitors

Dysfunctional and Dysregulated Nitric Oxide Synthases in Cardiovascular Disease: Mechanisms and Therapeutic Potential

Title Vascular nitric oxide : Beyond eNOS

Nitric oxide synthase: Biochemistry and molecular biology

Recent Studies on Inos Inhibitors from Biological Sources

Nitric oxide in the cardio-cerebrovascular system: Source, regulation and application

Role of Dietary Polyphenols in the Activity and Expression of Nitric Oxide Synthases: A Review

Controllable Nitric Oxide‐Delivering Platforms for Biomedical Applications

Regulation of Vascular Function by Nitric Oxide-Related S-nitrosylation

[Research progress in the regulation of endothelial nitric oxide synthase activity and cardiovascular diseases].

[Clinical significance of nitric oxide in hypertension]

Progress in the Development of Nitric Oxide-Releasing Biomaterials and Their Biomedical Applications

Study on the Technology of Nitric Oxide (no) Detection in Vitro and in Vivo

Nitric oxide synthase gene therapy for cardiovascular disease.

Nitric oxide synthases in the pathogenesis of cardiovascular disease: lessons from genetically modified mice

Advanced Nitric Oxide Generating Nanomedicine for Therapeutic Applications

Research Progress on Synthesis of Nitric Oxide Donor Compounds

Nitric oxide signaling in health and disease